{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:26:18Z","timestamp":1794576378241,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Our objective was to conduct a thorough evaluation of the burden of CKD and its associated anemia by age and sex at the global, regional, and national levels, with projections extending to 2050.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The data from the Global Burden of Diseases (GBD) 2021 were used to describe relevant indicators of CKD and its associated anemia. At different geographic levels, subgroup analysis was carried out by sex, age, and Socio-Demographic Index (SDI). The time trend was examined using the joinpoint regression and decomposition analyses, and predictive analysis was utilized to further estimate the disease burden to 2050.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The incidence, prevalence, mortality, and Disability-Adjusted Life Years (DALYs) of CKD, along with the prevalence and Years Lived with Disability (YLDs) of CKD-associated anemia, maintained a steady increase and would continue until 2050. In addition, the ASRs of mortality and DALYs attributable to CKD in 2021 were highest in low SDI regions. Regionally, CKD exhibited the greatest ASRs of mortality and DALYs in Central Latin America in 2021. Meanwhile, the disease burden of CKD and its associated anemia also showed significant differences at different national levels probably mainly due to population growth and aging. Moreover, the prediction analysis showed that the ASR of incidence attributable to CKD continued to increase.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>With the global population growth and aging, the disease burden of CKD and its associated anemia is still high and varies significantly at the global, regional, and national levels, which requires healthcare professionals to refine targeted interventions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04398-4","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:19:24Z","timestamp":1756289964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Global, regional, and national burden of chronic kidney disease and its associated anemia, 1990 to 2021 and predictions to 2050: an analysis of the global burden of disease study 2021"],"prefix":"10.1186","volume":"26","author":[{"given":"Qiao","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"2","key":"4398_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ckj\/sfac218","volume":"16","author":"Y Li","year":"2023","unstructured":"Li Y, Ning Y, Shen B, et al. Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: An analysis of the global burden of disease study 2019. Clin Kidney J. 2023;16(2):312\u201321.","journal-title":"Clin Kidney J"},{"issue":"1","key":"4398_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-024-00589-9","volume":"11","author":"P Romagnani","year":"2025","unstructured":"Romagnani P, Agarwal R, Chan JCN, et al. Chronic kidney disease. Nat Rev Dis Primers. 2025;11(1):8.","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl, 6","key":"4398_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.15683","volume":"26","author":"NM Selby","year":"2024","unstructured":"Selby NM, Taal MW. What every clinician needs to know about chronic kidney disease: Detection, classification and epidemiology. Diabetes Obes Metab. 2024;26(Suppl, 6):3\u201312.","journal-title":"Diabetes Obes Metab"},{"key":"4398_CR4","unstructured":"GBD. Diseases and injuries collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019. A systematic analysis for the global burden of disease study 2019. Lancet. 2019. 2020;396(10258):1204\u201322."},{"key":"4398_CR5","doi-asserted-by":"crossref","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017. A systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333.","DOI":"10.1016\/S0140-6736(19)32977-0"},{"key":"4398_CR6","doi-asserted-by":"crossref","unstructured":"GBD. Dalys and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017. A systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1859\u2013922.","DOI":"10.1016\/S0140-6736(18)32335-3"},{"key":"4398_CR7","doi-asserted-by":"crossref","unstructured":"Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016\u201340 for 195 countries and territories. Lancet. 2018;392(10159):2052\u201390.","DOI":"10.1016\/S0140-6736(18)31694-5"},{"key":"4398_CR8","doi-asserted-by":"crossref","unstructured":"Garcia Sanchez JJ, James G, Carrero JJ, et al. Health care resource utilization and related costs of patients with CKD from the United States: A report from the DISCOVER CKD retrospective cohort. Kidney Int Rep. 2023;8(4):785\u201395.","DOI":"10.1016\/j.ekir.2023.01.037"},{"issue":"3","key":"4398_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.kint.2018.11.011","volume":"95","author":"F Wang","year":"2019","unstructured":"Wang F, Yang C, Long J, et al. Executive summary for the 2015 annual data report of the China kidney disease network (CK-NET). Kidney Int. 2019;95(3):501\u201305.","journal-title":"Kidney Int"},{"key":"4398_CR10","unstructured":"GBD. Risk factors collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019. A systematic analysis for the global burden of disease study 2019. Lancet. 2019. 2020;396(10258):1223\u201349."},{"issue":"2","key":"4398_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/osp4.629","volume":"9","author":"S Nawaz","year":"2022","unstructured":"Nawaz S, Chinnadurai R, Al-Chalabi S, et al. Obesity and chronic kidney disease: A current review. Obes Sci Pract. 2022;9(2):61\u201374.","journal-title":"Obes Sci Pract"},{"issue":"1","key":"4398_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2215\/CJN.0000000000000017","volume":"18","author":"J Hu","year":"2023","unstructured":"Hu J, Ke R, Teixeira W, et al. Global, regional, and national burden of CKD due to glomerulonephritis from 1990 to 2019: A systematic analysis from the global burden of disease study 2019. Clin J Am Soc Nephrol. 2023;18(1):60\u201371.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4398_CR13","doi-asserted-by":"crossref","unstructured":"Taderegew MM, Wondie A, Terefe TF, et al. Anemia and its predictors among chronic kidney disease patients in sub-Saharan African countries: A systematic review and meta-analysis. PLoS One. 2023;18(2):e0280817.","DOI":"10.1371\/journal.pone.0280817"},{"key":"4398_CR14","doi-asserted-by":"crossref","unstructured":"McCullough PA. Anemia of cardiorenal syndrome. Kidney Int Suppl. 2011. 2021;11(1):35\u201345.","DOI":"10.1016\/j.kisu.2020.12.001"},{"issue":"7","key":"4398_CR15","doi-asserted-by":"publisher","first-page":"e0236132","DOI":"10.1371\/journal.pone.0236132","volume":"15","author":"T Sofue","year":"2020","unstructured":"Sofue T, Nakagawa N, Kanda E, et al. Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan chronic kidney disease database (J-CKD-DB). PLoS One. 2020;15(7):e0236132.","journal-title":"PLoS One"},{"issue":"10","key":"4398_CR16","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","volume":"40","author":"V Jha","year":"2023","unstructured":"Jha V, Al-Ghamdi SMG, Li G, et al. Global economic burden associated with chronic kidney disease: A pragmatic review of medical costs for the inside CKD research programme. Adv Ther. 2023;40(10):4405\u201320.","journal-title":"Adv Ther"},{"key":"4398_CR17","doi-asserted-by":"publisher","first-page":"168189","DOI":"10.1016\/j.scitotenv.2023.168189","volume":"908","author":"J Song","year":"2024","unstructured":"Song J, Pan T, Xu Z, et al. A systematic analysis of chronic kidney disease burden attributable to lead exposure based on the global burden of disease study 2019. Sci Total Environ. 2024;908:168189.","journal-title":"Sci Total Environ"},{"key":"4398_CR18","doi-asserted-by":"publisher","first-page":"1078371","DOI":"10.3389\/fnut.2023.1078371","volume":"10","author":"W Liu","year":"2023","unstructured":"Liu W, Zhou L, Yin W, et al. Global, regional, and national burden of chronic kidney disease attributable to high sodium intake from 1990 to 2019. Front Nutr. 2023;10:1078371.","journal-title":"Front Nutr"},{"key":"4398_CR19","doi-asserted-by":"crossref","unstructured":"Qu X, Liu C, Sun L, Sheng Z. Global burden of type 1 diabetes mellitus related chronic kidney disease among adolescents and young adults, and projections to 2035: Results from the global burden of disease study 2021. Diabetes Metab J. 2025, Epub ahead of print.","DOI":"10.4093\/dmj.2024.0544"},{"key":"4398_CR20","doi-asserted-by":"crossref","unstructured":"Zhakhina G, Mussina K, Yerdessov S, et al. Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014\u20132020 and forecasting future trends of prevalence and mortality for 2030. Ren Fail. 2024;46(1):2326312.","DOI":"10.1080\/0886022X.2024.2326312"},{"issue":"3","key":"4398_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","volume":"94","author":"Y Xie","year":"2018","unstructured":"Xie Y, Bowe B, Mokdad AH, et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567\u201381.","journal-title":"Kidney Int"},{"key":"4398_CR22","doi-asserted-by":"crossref","unstructured":"GBD. Diseases and injuries collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021. A systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2133\u201361.","DOI":"10.1016\/S0140-6736(24)00757-8"},{"key":"4398_CR23","unstructured":"GBD. Risk factors collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021. A systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2162\u2013203."},{"issue":"10062","key":"4398_CR24","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: The GATHER statement. Lancet. 2016;388(10062):e19\u201323.","journal-title":"Lancet"},{"key":"4398_CR25","unstructured":"Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO, 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150."},{"key":"4398_CR26","doi-asserted-by":"crossref","unstructured":"Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017. A systematic analysis for the global burden of disease study 2017. Lancet. 2019;394(10204):1145\u201358.","DOI":"10.1016\/S0140-6736(19)30427-1"},{"key":"4398_CR27","doi-asserted-by":"crossref","unstructured":"GBD. Risk factor collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017. A systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1923\u201394.","DOI":"10.1016\/S0140-6736(18)32225-6"},{"key":"4398_CR28","unstructured":"GBD. Demographics collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019. A comprehensive demographic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1160\u2013203."},{"key":"4398_CR29","doi-asserted-by":"crossref","unstructured":"Rezaei F, Mazidimoradi A, Rayatinejad A, Allahqoli L, Salehiniya H. Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data. Thorac Cancer. 2023;14(18):1668\u2013706.","DOI":"10.1111\/1759-7714.14912"},{"key":"4398_CR30","unstructured":"GBD. Causes of death collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021. A systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2100\u201332."},{"issue":"10","key":"4398_CR31","doi-asserted-by":"publisher","first-page":"103407","DOI":"10.1016\/j.autrev.2023.103407","volume":"22","author":"DP Li","year":"2023","unstructured":"Li DP, Han YX, He YS, et al. A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040. Autoimmun Rev. 2023;22(10):103407.","journal-title":"Autoimmun Rev"},{"key":"4398_CR32","doi-asserted-by":"crossref","unstructured":"Hu W, Fang L, Zhang H, Ni R, Pan G. Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in China. Public Health. 2022;208:89\u201397.","DOI":"10.1016\/j.puhe.2022.04.015"},{"key":"4398_CR33","doi-asserted-by":"crossref","unstructured":"Zhao X, Liu S, Zou Z, Liang C. Global, regional, and national prevalence of prostate cancer from 1990 to 2021: A trend and health inequality analyses. Front Public Health. 2025;13:1595159.","DOI":"10.3389\/fpubh.2025.1595159"},{"key":"4398_CR34","doi-asserted-by":"crossref","unstructured":"GBD. Disease and injury incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017. A systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789\u2013858.","DOI":"10.1016\/S0140-6736(18)32279-7"},{"issue":"2","key":"4398_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.120.14874","volume":"76","author":"T Beaney","year":"2020","unstructured":"Beaney T, Schutte AE, Stergiou GS, et al. May measurement Month, 2019: The global blood pressure screening campaign of the International society of hypertension. Hypertension. 2020;76(2):333\u201341.","journal-title":"Hypertension"},{"issue":"10","key":"4398_CR36","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1111\/jch.13672","volume":"21","author":"EK Tannor","year":"2019","unstructured":"Tannor EK, Sarfo FS, Mobula LM, et al. Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: A multicenter cross-sectional study. J Clin Hypertens (greenwich). 2019;21(10):1542\u201350.","journal-title":"J Clin Hypertens (greenwich)"},{"issue":"9","key":"4398_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/10408444.2023.2168178","volume":"52","author":"J Rao","year":"2023","unstructured":"Rao J, Peng T, Li N, et al. Nephrotoxicity induced by natural compounds from herbal medicines - a challenge for clinical application. Crit Rev Toxicol. 2023;52(9):757\u201378.","journal-title":"Crit Rev Toxicol"},{"issue":"10","key":"4398_CR38","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2215\/CJN.11571017","volume":"13","author":"B Yang","year":"2018","unstructured":"Yang B, Xie Y, Guo M, et al. Nephrotoxicity and Chinese herbal medicine. Clin J Am Soc Nephrol. 2018;13(10):1605\u201311.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"4398_CR39","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello AK, Okpechi IG, Levin A, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024;12(3):e382\u201395.","journal-title":"Lancet Glob Health"},{"issue":"9981","key":"4398_CR40","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet. 2015;385(9981):1975\u201382.","journal-title":"Lancet"},{"issue":"8","key":"4398_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2337\/dc24-0335","volume":"47","author":"P Rossing","year":"2024","unstructured":"Rossing P, Groop PH, Singh R, Lawatscheck R, Tuttle KR. Prevalence of chronic kidney disease in type 1 diabetes among adults in the U.S. Diabetes Care. 2024;47(8):1395\u201399.","journal-title":"Diabetes Care"},{"issue":"10027","key":"4398_CR42","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4\u00b74 million participants. Lancet. 2016;387(10027):1513\u201330.","journal-title":"Lancet"},{"issue":"6","key":"4398_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11906-022-01183-8","volume":"24","author":"PJ Connelly","year":"2022","unstructured":"Connelly PJ, Currie G, Delles C. Sex differences in the prevalence, outcomes and management of hypertension. Curr Hypertens Rep. 2022;24(6):185\u201392.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"4398_CR44","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12916-024-03745-w","volume":"22","author":"B Shang","year":"2024","unstructured":"Shang B, Yao Y, Yin H, et al. In utero,, childhood, and adolescence tobacco smoke exposure, physical activity, and chronic kidney disease incidence in adulthood: Evidence from a large prospective cohort study. BMC Med. 2024;22(1):528.","journal-title":"BMC Med"},{"issue":"1","key":"4398_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MNH.0000000000000463","volume":"28","author":"JM Valdivielso","year":"2019","unstructured":"Valdivielso JM, Jacobs-Cach\u00e1 C, Soler MJ. Sex hormones and their influence on chronic kidney disease. Curr Opin Nephrol Hypertens. 2019;28(1):1\u20139.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"4398_CR46","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2337\/db23-0807","volume":"73","author":"HJ Lee","year":"2024","unstructured":"Lee HJ, Min L, Gao J, et al. Female protection against diabetic kidney disease is regulated by kidney-specific AMPK activity. Diabetes. 2024;73(7):1167\u201377.","journal-title":"Diabetes"},{"issue":"4","key":"4398_CR47","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ekir.2016.07.004","volume":"1","author":"G Filler","year":"2016","unstructured":"Filler G, Ramsaroop A, Stein R, et al. Is testosterone detrimental to renal function? Kidney Int Rep. 2016;1(4):306\u201310.","journal-title":"Kidney Int Rep"},{"issue":"9","key":"4398_CR48","doi-asserted-by":"publisher","first-page":"e0291150","DOI":"10.1371\/journal.pone.0291150","volume":"18","author":"EO Abanikanda","year":"2023","unstructured":"Abanikanda EO, Dada JT, Ogunjumo RA. Fiscal deficit in sub-saharan Africa: A new intuition from the institution and political drivers. PLoS One. 2023;18(9):e0291150.","journal-title":"PLoS One"},{"issue":"2","key":"4398_CR49","doi-asserted-by":"publisher","first-page":"100403","DOI":"10.1016\/j.xkme.2021.11.001","volume":"4","author":"R Oluyombo","year":"2021","unstructured":"Oluyombo R, Banjo Oguntade H, Soje M, Obajolowo O, Karim M. Obesity and CKD in Sub-Saharan Africa: A narrative review. Kidney Med. 2021;4(2):100403.","journal-title":"Kidney Med"},{"issue":"1","key":"4398_CR50","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1186\/s12889-022-14959-z","volume":"22","author":"Y Jian","year":"2022","unstructured":"Jian Y, Zhu D, Zhou D, et al. ARIMA model for predicting chronic kidney disease and estimating its economic burden in China. BMC Public Health. 2022;22(1):2456.","journal-title":"BMC Public Health"},{"issue":"6","key":"4398_CR51","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ekir.2021.03.901","volume":"6","author":"B Talbot","year":"2021","unstructured":"Talbot B, Athavale A, Jha V, Gallagher M. Data challenges in addressing chronic kidney disease in low- and lower-middle-income countries. Kidney Int Rep. 2021;6(6):1503\u201312.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"4398_CR52","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/ije\/dyac227","volume":"52","author":"C Luo","year":"2023","unstructured":"Luo C, Wang Y, Su Q, et al. Mapping schistosomiasis risk in Southeast Asia: A systematic review and geospatial analysis. Int J Epidemiol. 2023;52(4):1137\u201349.","journal-title":"Int J Epidemiol"},{"issue":"12","key":"4398_CR53","doi-asserted-by":"publisher","first-page":"e012675","DOI":"10.1136\/bmjgh-2023-012675","volume":"8","author":"R Verma","year":"2023","unstructured":"Verma R, Commons RJ, Gupta A, et al. Safety and efficacy of primaquine in patients with plasmodium vivax malaria from South Asia: A systematic review and individual patient data meta-analysis. BMJ Glob Health. 2023;8(12):e012675.","journal-title":"BMJ Glob Health"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04398-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:35:15Z","timestamp":1757442915000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04398-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4398"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04398-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and consent were not required as this study was based on publicly available data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"495"}}